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transients suggest that slowing of Ca 2ϩ release is a critical mediator of CHF progression. excitation-contraction coupling; cardiac contraction; calcium; cardiomyocytes CA 2ϩ IS A KEY PLAYER INVOLVED in the series of events leading to cardiomyocyte contraction, referred to as excitation-contraction coupling. During the cardiac action potential (AP), Ca 2ϩ enters the cytosol through voltage-gated L-type Ca 2ϩ channels located in the cell membrane (sarcolemma). This triggers a massive release of Ca 2ϩ from the sarcoplasmic reticulum (SR), and contraction occurs as Ca 2ϩ binds to the myofilaments. The cell relaxes as Ca 2ϩ is recycled into the SR by the SR Ca 2ϩ
ATPase (SERCA), and extruded from the cell, mainly by the Na ϩ /Ca 2ϩ exchanger (NCX). SERCA activity is regulated by its endogenous inhibitor phospholamban (PLB). Phosphorylation of PLB relieves the inhibition.
Reduced myocardial contractility is a hallmark feature of the failing human heart (28) . Cardiomyocytes isolated from failing myocardium are widely reported to exhibit reduced contraction magnitudes and slowed relaxation (for review, see Ref. 23 ). Similar alterations occur in Ca 2ϩ transients as SR Ca 2ϩ release is depressed and re-uptake is slowed (7) . Interestingly, the rate of rise of the Ca 2ϩ transient and myocyte shortening velocity have received less attention in both in vivo and in vitro heart failure studies. However, slowed contractions and Ca 2ϩ transients with prolonged peaks have been observed in human heart failure (7, 21, 43) and animal heart failure models (4, 9, 34) . Such alterations would be expected to be detrimental since shortening velocity together with force determines contractile power (25) .
In the present study, we assess the progression of congestive heart failure (CHF) following myocardial infarction (MI) in mice, from early to chronic stages both in vivo and in isolated cardiomyocytes. Using this model, our laboratory has previously reported increased function in viable myocardium during early CHF with larger contractions and Ca 2ϩ transients in isolated myocytes (36, 38) . Importantly, Ca 2ϩ transients were observed to be slower to peak in CHF than in sham, although prolongation of the time to peak (TTP) contraction was not observed at this early stage of the disease (38) . We hypothesize that prolongation of the Ca 2ϩ transient TTP and slowing of contraction are critical to deterioration of cardiac function during CHF progression.
METHODS

Mouse model of CHF following MI.
All animal experiments were performed according to National Institutes of Health guidelines (NIH publication no 85-23, revised 1996) and approved by the Norwegian National Animal Research Committee. MI was induced by left coronary artery ligation in 9-wk-old female mice (C57BL/6) as previously described (36, 38, 53) . Sham-operated animals (sham) were subjected to the same surgical procedure, without ligation of the coronary artery.
Using echocardiography, mice that had developed CHF 1 wk after surgery were selected for inclusion in the study. Criteria for CHF included large infarction size (Ͼ40% of left ventricular circumference) and increased left atrial diameter (Ͼ2.0 vs. 1.3 mm in sham) (as described in Ref. 17) . Our laboratory has reported reduced cardiac function and pulmonary congestion in animals selected by these criteria (17, 38) . Experiments were performed 1 and 10 wk after surgery.
Echocardiographic measurements and harvesting of cardiac tissue. Echocardiographic characterization of heart function was performed on anesthetised (ϳ2% isoflurane) but self-breathing mice, as described previously (17) . M-mode measurements were employed to investigate left ventricle (LV) fractional shortening, posterior wall thickening (PWT), and PWT velocity (PWTV).
Anesthetized animals (ϳ2% isoflurane) were killed by cervical dislocation, and hearts and lungs were rapidly removed. Viable septal heart tissue (excluding MI border zone) was either used for single-cell experiments or rapidly frozen in liquid nitrogen for protein analysis.
Single-cell experiments. Cardiomyocytes were enzymatically isolated as described in Ref. 36 . During all experiments except L-type Ca 2ϩ current (ICa,L) recordings, cardiomyocytes were superfused with HEPES tyrode solution containing (in mM) 140 NaCl, 1 CaCl 2, 0.5 MgCl 2, 5.0 HEPES, 5.5 glucose, 0.4 NaH2PO4, and 5.4 KCl (pH 7.4). All experiments were performed at 22°C.
Digital photographs were obtained of randomly selected cells for measurement of two-dimensional cardiomyocyte size.
Contractions were measured using a video edge detector (Crescent Electronics, Sandy, UT) coupled to a television monitor. Cytosolic Ca 2ϩ was monitored in fluo 4-AM-loaded cells using an LSM 510 confocal fluorescence imaging system (Zeiss, Jena, Germany) in line-scan mode, as previously described (36 Statistics. Numerical data are presented as means Ϯ SE. Student's t-test (paired or unpaired) was used to evaluate statistical difference, except for survival curves where the log-rank test was used. Statistically significant difference was accepted when P Ͻ 0.05.
RESULTS
Survival and morphological characteristics. Mice that exhibited CHF at 1 wk after MI surgery were included in the study (see METHODS) . Figure 1A shows that 40% of these CHF animals died before reaching the end of the study (10 wk), whereas all animals survived in the sham group (P Ͻ 0.05).
Animal and cell characteristics at the 1-and 10-wk time points are displayed in Table 1 . Lung weight and lung weightto-body weight ratios were increased in both CHF groups, indicating pulmonary congestion. Although not observed in early (1 wk) CHF, cardiomyocyte hypertrophy was present in chronic (10 wk) CHF, since cardiomyocyte length, area, and capacitance values were larger than in 10-wk sham.
In vivo cardiac function. In vivo heart function was examined by echocardiography and is summarized in Fig. 1 
, B-D.
Overall cardiac performance, measured as LV fractional shortening (Fig. 1B) , was already depressed at 1 wk of CHF (37 Ϯ 4% sham values; P Ͻ 0.05), likely due to the presence of the large MI. LV fractional shortening was significantly further reduced in 10-wk CHF (26 Ϯ 3% sham values; P Ͻ 0.05). We observed increased local function in surviving myocardium in 1-wk CHF, manifested as enhanced PWT. This early compensation, which is in agreement with our laboratory's previous observations (38) , was not observed in chronic CHF. As well, PWTV was unaltered in early CHF relative to sham but significantly slowed in 10-wk CHF. Thus CHF progression in post-MI mice involves decline of both global and local cardiac function.
Larger contractions and Ca 2ϩ transients in CHF cardiomyocytes. Contractile function was examined in cardiomyocytes isolated from the viable septum of CHF and sham hearts. Representative traces are shown in Fig. 2 , A and B, during field stimulation at a range of frequencies (0.5-5 Hz). In contrast to our in vivo observations, we observed larger contractions of septal myocytes at both time points of CHF compared with sham. Mean data show that contraction magnitudes in CHF were approximately double sham values at all frequencies tested (Fig. 2, C and D) . Contraction amplitudes were not significantly altered between 1-and 10-wk CHF. 
Progressively slower contractions and Ca
2ϩ transients in CHF. We more closely examined contraction and Ca 2ϩ transient recordings to determine whether altered kinetics could explain our in vivo observations. Figure 4 , A and B, shows representative contractions (1 Hz) on an expanded time scale. Although TTP contraction (broken lines) was unaltered in early CHF vs. sham, it was prolonged by 15 Ϯ 6% (P Ͻ 0.05) in 10-wk CHF (Fig. 4C ). In addition, relaxation time was reduced in 1-wk CHF cells (73 Ϯ 4% of sham values; P Ͻ 0.05) but was not significantly different in 10-wk CHF and sham ( Caffeine-elicited Ca 2ϩ transients were larger in 1-wk CHF cells compared with sham (150 Ϯ 7% sham values; P Ͻ 0.05), indicating increased SR Ca 2ϩ content (Fig. 6C) . A significantly smaller elevation in SR load was observed in 10-wk CHF (126 Ϯ 7% of sham; P Ͻ 0.05). SR Ca 2ϩ reuptake was more rapid in early CHF (188 Ϯ 13% sham values; P Ͻ 0.05), whereas rate constant values were similar in chronic CHF and sham (Fig. 6D) . The rate of sarcolemmal Ca 2ϩ extrusion was also increased in 1-wk ( ϭ 247.3 Ϯ 31.2% sham values; P Ͻ 0.05) but not 10-wk CHF (Fig. 6E) . Figure 6F shows that SR-dependent Ca 2ϩ reuptake remained proportional to sarcolemmal Ca 2ϩ extrusion in both 1-and 10-wk CHF compared with sham. Western blots of Ca 2ϩ handling proteins. Figure 6G shows protein levels of NCX, SERCA2a, and PLB in 1-and 10-wk sham and CHF. Representative blots are also shown. NCX levels tended to be increased in both 1-and 10-wk CHF hearts compared with sham (22.1 Ϯ 10.2 and 24.6 Ϯ 7.7%, respectively; P ϭ not significant), although only 1-wk CHF cells displayed improved Ca 2ϩ extrusion during caffeine exposure (Fig. 6E) . Levels of SERCA2a were not significantly different in CHF and sham at either time point. PLB expression was downregulated in 1-wk CHF (71.7 Ϯ 5.8% of sham levels; P Ͻ 0.05) but was not significantly different between 10-wk CHF and sham. Levels of phosphorylated PLB at Ser16 and Thr17 were not altered at either time point (data not shown). These observations are consistent with a marked increase in SERCA function and rate of SR reuptake in 1-wk CHF (Fig. 6D) . Measurements of L-type Ca 2ϩ channel protein abundance were not altered in chronic CHF vs. sham (data not shown), and our laboratory has previously observed no significant alteration in 1-wk CHF (38) .
Increased Figure 7 , A and C, shows representative APs at the 1-and 10-wk time points, respectively. AP configuration was not significantly altered in early CHF (Fig. 7B) . However, marked AP prolongation was observed in chronic CHF as time to 20, 50, and 70% repolarization were increased by 40 Ϯ 19, 117 Ϯ 33, and 226 Ϯ 97% (P Ͻ 0.05) of sham values, respectively (Fig. 7D ). Resting membrane potential was similar in CHF and sham (data not shown).
The AP recordings from 10-wk CHF and sham shown in Fig. 7C were employed as stimulus waveforms in normal cardiomyocytes. Figure 7E shows that the Ca 2ϩ transient amplitude was 24.6 Ϯ 17.1% larger (P Ͻ 0.05) during stimulation with the 10-wk CHF AP than with the sham AP. However, switching the AP stimulus did not alter the TTP or decline of the Ca 2ϩ transient (Fig. 7, F and G, respectively) . Integrated, nifedipine-sensitive I Ca,L was augmented during the slower repolarizing CHF AP (Fig. 7, H and I) , and caffeineelicited Ca 2ϩ transients were increased in magnitude (Fig. 7J ). Thus AP changes in 10-wk CHF myocytes likely underlie the increased SR content and larger Ca 2ϩ transients observed in these cells.
DISCUSSION
In this study, we examined the progression of CHF in post-MI mice. Between early and chronic CHF time points (1 wk and 10 wk post-MI), we observed increased mortality, development of hypertrophy, and a progressive decrease in overall cardiac performance. The noninfarcted posterior wall exhibited a compensatory increase in systolic thickening in early CHF. Progression to chronic CHF showed loss of this compensation and also slowing of shortening velocity. Isolated cardiomyocyte contractions and Ca 2ϩ transients were larger in CHF than in sham at both time points due to increased Ca 2ϩ influx and greater SR Ca 2ϩ content. However, CHF progression was associated with slowing of both the Ca 2ϩ transient and myocyte shortening, manifested as longer TTP values. These findings suggest that slowing of SR Ca 2ϩ release and myocyte contraction are critical to deterioration of cardiac function during CHF.
Slower cardiomyocyte contractions in CHF.
A number of echocardiographic studies have observed that contraction is slower in the in vivo failing heart. Clinical studies have reported reduced LV systolic tissue velocity in heart failure patients and have demonstrated that this parameter can be useful in diagnosis (51, 54) . Comparable observations have been made in animal models of heart failure. Pressure overload in rodents reduces circumferential shortening velocity (8, 29) , and our present observation of reduced LV systolic tissue velocity in the viable myocardium is in agreement with other A and B) was similar in 1-wk CHF and sham but increased in 10-wk CHF. D: time to 50% relaxation was reduced in early but not in chronic CHF. *Significant difference between CHF and sham (P Ͻ 0.05; 1-wk sham, n ϭ ϭ19; 1-wk CHF, n ϭ 15; 10-wk sham, n ϭ 24; 10-wk CHF, n ϭ 19). chronic postinfarction studies (34, 47) . In addition, many studies report a slowed rate of pressure development (dP/dt) in failing animals, which may result from reduced magnitude and/or velocity of contraction (17, 47) .
Examinations of cardiomyocytes isolated from failing hearts have commonly reported reduced contraction magnitude and slowed relaxation (22) . Although contraction TTP data has not been reported in many of these studies, prolonged contractions have been observed by some in failing cardiomyocytes from both humans (13, 15, 22, 43) and animal models (9, 30, 45, 46) . In our opinion, however, the importance of slowed myocyte contractions for the failing phenotype has not received adequate attention. Our present findings show that prolongation of TTP of myocyte contraction occurs progressively during CHF and parallels the time course of alterations in PWTV in vivo. Such a reduction in contraction velocity would be expected to be detrimental for overall cardiac function since contractile power is dependent on both force and velocity, as defined by the Hill equation (25) . Indeed, we observed that declining PWTV during CHF progression was associated with deterioration of global performance and increased mortality.
Prolongation of TTP of myocyte contractions in CHF cells was associated with progressive slowing of Ca 2ϩ release, suggesting that deranged Ca 2ϩ homeostasis is a critical contributor to CHF development. Interestingly, we observed prolongation of the TTP of the Ca 2ϩ transient already at 1 wk of CHF, before increases in TTP contraction were observed. However, since the peak of the Ca 2ϩ transient precedes the peak of the contraction, the decline rate of the Ca 2ϩ transient should also be considered. In 1-wk CHF, the Ca 2ϩ transient declined more rapidly than in sham cells due to increased rates of SR reuptake and transsarcolemmal extrusion. Thus the total time of the Ca 2ϩ transient was not greatly altered, and TTP contraction was unaffected. In 10-wk CHF, prolongation of the Ca 2ϩ transient TTP was more pronounced and Ca 2ϩ decline kinetics were no longer altered, resulting in significant slowing of contraction.
Our present findings, together with our laboratory's previous observations (36) , suggest that structural alterations underlie (48), T-tubule loss in pigs with chronically ischemic myocardium (24) , and following experimental reductions in T-tubule density (33, 35) . However, alterations in AP configuration during heart failure might also contribute to slowing of Ca 2ϩ release. Switching the AP stimulus from a normal human AP to a failing human AP reduces peak I Ca,L , which desynchronizes Ca 2ϩ release and prolongs TTP (for review, see Ref. 42 ). However, repolarization is much more dramatically slowed during the failing human AP than during the failing mouse AP. More modest AP prolongation in our model increased net I Ca,L , which is in agreement with findings from other rodent studies (42) . Although we have not examined Ca 2ϩ release synchrony in the present study, we were unable to detect prolongation of TTP values when we switched from the sham AP stimulus to the CHF AP. Thus our past (36) and present findings support the notion that T-tubular alterations and not changes in AP configuration underlie slowing of Ca 2ϩ release in failing cardiomyocytes. Other unknown mechanisms could also theoretically contribute, such as altered phosphorylation and uncoupling of ryanodine receptors (37) .
Larger contractions and Ca 2ϩ transients during CHF: the post-MI mouse model. We observed that contractions and Ca 2ϩ transients in cardiomyocytes from failing hearts were increased in magnitude across a range of frequencies. This is in stark contrast to what is generally reported in human heart failure (6). However, results from post-MI rodent models have been inconsistent, since increased (1, 9, 12), decreased (14, 19, 55) , and unchanged (20, 49) contraction magnitudes have been reported. Large infarctions are necessary to trigger CHF in our mouse model (17) , and we believe that animals are able to survive due to their ability to increase function in the small amount of viable myocardium. The compensations that enable this augmentation of function are intriguing. I Ca,L is increased in both early and chronic CHF. In early CHF, this increase results from greater peak current, which corroborates similar observations in rats 1 wk after MI induction (39) . Interestingly, we observed a slight leftward shift of the current-voltage relationship, which may reflect increased PKA-dependent phosphorylation (11) . In chronic CHF, we did not observe altered peak I Ca,L during voltage-step protocols, which is in agreement with the consensus from other chronic heart failure studies (6) . However, greater integrated I Ca,L resulted from AP prolongation at this time point. Surprisingly, I Ca,L inactivation kinetics were not different in CHF and sham at either 1 or 10 wk, despite greater SR Ca 2ϩ release in CHF. We have previously hypothesized that T-tubular disorganization during CHF may increase the distance between ryanodine receptors and L-type Ca 2ϩ channels (36), limiting Ca 2ϩ -dependent inactivation of I Ca,L . Another possibility is that differences in I Ca,L kinetics were somewhat obscured in our experiments, since cesium-containing solutions are reported to blunt SR function (32) . SR Ca 2ϩ content was increased in cardiomyocytes from CHF mice, but by different mechanisms at the two time points. Reduced PLB levels in 1-wk CHF resulted in greater SERCA activity, as manifested by a larger rate constant of SR Ca 2ϩ reuptake. In 10-wk CHF, SERCA and PLB levels were not altered. However, since greater Ca 2ϩ influx during AP prolongation was not accompanied by increased Ca 2ϩ extrusion in these cells, enhanced SR Ca 2ϩ uptake is expected. Indeed, we observed that switching the stimulus waveform from the sham AP to the CHF AP increased SR content. Our findings contrast with the general consensus of reduced SR Ca 2ϩ content in chronically failing cells from humans and larger non-rodent models. Depressed SERCA function has been widely reported in these studies, due to reduced protein levels of SERCA or increased inhibition by PLB (6) .
Greater Ca 2ϩ extrusion resulting from increased NCX function is also reported in human heart failure (23) and may further contribute to reductions in SR content. We observed a tendency toward increased NCX levels in both 1-wk and 10-wk CHF hearts, although Ca 2ϩ efflux was only enhanced at the 1-wk time point. We speculate that increased cytosolic Na ϩ concentration in chronic CHF (40) may limit NCX-mediated Ca 2ϩ extrusion, which in turn promotes SR Ca 2ϩ uptake. AP prolongation may additionally strengthen the Ca 2ϩ transient since more time spent at depolarized membrane potentials can promote Ca 2ϩ entry via reverse-mode NCX (52) . However, although AP prolongation in larger species is known to slow NCX-mediated Ca 2ϩ removal (3), we observed that even the prolonged AP in CHF mice is too brief to slow Ca 2ϩ transient decay. Indeed, an examination of the data in Fig. 7 shows that, during stimulation with the CHF AP, the cell membrane is already repolarized shortly after the peak of the Ca 2ϩ transient. Although isolated cardiomyocyte contractions were increased in both early and chronic CHF, we observed that in vivo contraction of the posterior wall (as measured by PWT) was only increased at the 1-wk time point. The reasons for this discrepancy are unclear. However, we speculate that, since myocytes in the posterior wall are "tethered" to the neighboring infarcted region, changes in the composition and stiffness of the scar may be critical. For example, an infarct that stretches during systole will absorb energy of the adjacent ventricle (26) . Conversely, an extremely stiff infarct might also impair shortening of neighboring myocardium (26) . Since scar formation and healing are known to occur over several weeks following an ischemic event (27) , myocytes in the posterior wall may, therefore, be subjected to very different loading conditions at 1 and 10 wk of CHF. We suggest that the slowing of myocyte contraction during this time could be involved in the reduction of PWT. For example, a slower, weaker contraction might be less able to overcome the constraints of a very stiff infarction, which could reduce the extent to which the posterior wall thickens. Additional explanations for the discrepacy between contraction magnitude in vivo and in vitro might include stiffening of the myocardium due to fibrosis or dyssynchronous contraction in the intact myocardium. Importantly, hypertrophy also develops between 1 and 10 wk of CHF, which further complicates the translation of observations in isolated cardiomyocytes to the intact myocardium. In this regard, employing MRI to examine local myocardial strain may be helpful in future work.
We observed that both CHF and sham cells exhibited negative relationships between Ca 2ϩ transient amplitude and frequency, although contraction amplitude was maintained as frequency was increased. This "frequency-induced myofilament sensitization" was first described by Gao and coworkers (18) and is an unusual characteristic of murine cardiac muscle. Increased diastolic intracellular Ca 2ϩ concentration levels at higher frequencies are likely involved in this phenomenon, since the starting point for contraction is moved toward the steep portion of the tension-pCa relation (2, 18) . In this situation, changes in Ca 2ϩ transient magnitude would be amplified at the level of the myofilaments. Such an effect may explain our finding that CHF contractions were double sham values at 5 Hz, whereas Ca 2ϩ transient amplitudes were only increased by ϳ50%. Intrinsic differences in myofilament Ca 2ϩ sensitivity have also been reported in failing heart by some (14) , but this finding remains controversial (23). We have not examined myofilament Ca 2ϩ sensitivity in this study. Our CHF model differs from many others in that overall cardiac function is depressed from early stages due to the presence of a very large MI. However, the increased function we have observed in noninfarcted myocardium at 1-wk CHF resembles that reported in some animal models of nonfailing, compensated hypertrophy (see review in Ref. 5). Several studies have observed greater basal I Ca,L (31, 41) and increased SR content (10, 44) in hypertrophied cardiomyocytes, which parallels our observations. Although we did not observe significant cardiomyocyte hypertrophy in 1-wk CHF, we have previously reported that hypertrophic signaling pathways are activated at this time point (38) and that cardiomyocyte hypertrophy does indeed occur a short time later (36) . As heart failure progresses, the compensations that promote hyperfunction during early stages of hypertrophy are lost. However, AP prolongation occurs, and in our model this maintains larger Ca 2ϩ transients and contractions in myocytes during chronic CHF. In contrast, AP prolongation in larger mammals decreases Ca 2ϩ transient magnitude (42), as discussed above. Thus intrinsic differences in AP configuration between rodents and non-rodents appear to at least partly account for speciesdependent differences in the magnitude of myocyte contractions during chronic CHF. Despite the apparent advantages of AP prolongation for Ca 2ϩ handling in murine myocytes, we do not believe that 10-wk CHF mice should be considered to be in a compensatory state. Between 1 and 10 wk of CHF, mortality markedly increased as both local and global cardiac function declined. Waiting to even later time points might further decrease survival and impair cardiac function, but we do not believe that isolated myocyte contraction amplitude would be reduced since AP prolongation is unlikely to be reversed. It is debatable then whether the post-MI mouse model produces "failing myocytes," since this term has been most commonly used to describe myocytes with reduced contraction magnitudes. However, our findings suggest that, in some instances, myocytes with slowed contraction kinetics might also be described as "failing."
Alterations in Ca 2ϩ homeostasis appear to be tightly orchestrated in CHF. We observed that the balance between Ca 2ϩ cycling across the SR and sarcolemma was maintained in CHF at both time points and was not different from sham (Fig. 5F ). For example, the compensations that promote increased function during early CHF involve proportional increases in the rates of SR Ca 2ϩ re-uptake and transsarcolemmal extrusion. In this situation, the increased Ca 2ϩ extrusion rate may be important for preventing excessive SR Ca 2ϩ re-uptake and arrhythmia. At the same time, greater Ca 2ϩ extrusion without enhanced SR re-uptake would be expected to decrease SR content and reduce function. Thus proportionally increasing transsarcolemmal and SR Ca 2ϩ fluxes appears to be a secure strategy for increasing myocyte function and might even be appropriate for treatment of heart failure patients. Mice are clearly very adept at altering Ca 2ϩ handling to maintain contraction magnitude and likely possess greater ability than humans to compensate for the presence of an infarction. However, mice, like humans, are unable to maintain the rate of rise of the Ca 2ϩ transient following MI. This deficiency appears to be critical in promoting decompensation in late CHF, characterized by reduced in vivo function and increased mortality.
In conclusion, we observed that deteriorating cardiac performance during CHF in post-MI mice involves slowing of contraction in the noninfarcted myocardium. CHF progression is also associated with prolongation of contraction in isolated myocytes and not reduction in contraction magnitude. Similar alterations in Ca 2ϩ transients point to slowing of Ca 2ϩ release as a critical mediator of declining myocardial function during CHF.
